After 15 long years of lab-based research, Harvard researcher Doug Melton and his team have finally been able to convert stem cells to insulin-producing beta cells. The research was published yesterday in the scientific journal Cell. In lab trials, the beta cells still produced insulin after six months–previously, the beta cells would stop producing insulin and die after only a few days. This success has opened the door for cell replacement therapies in patients with T1D. Significantly, it could mean an end to daily insulin injections and hypoglycemia. This is good news indeed!
Here’s more from CBS: